Table 1.
Baseline characteristics of the subjects enrolled
| Variables | Telmisartan group (n = 42) | Amlodipine group (n = 51) |
|---|---|---|
| Male, n (%) | 20 (47.6) | 26 (50.1) |
| Age (years) | 65 ± 10 | 58 ± 7 |
| BMI (kg/m2) | 27.0 ± 4.0 | 25.0 ± 3.3 |
| SBP (mmHg) | 158 ± 13 | 150 ± 9 |
| DBP (mmHg) | 91 ± 10 | 92 ± 7 |
| PP (mmHg) | 68 ± 15 | 59 ± 10 |
| MAP (mmHg) | 113 ± 9 | 112 ± 6 |
| HR (bpm) | 77 ± 9 | 74 ± 8 |
| Cigarette smoking, n (%) | 10 (23.8) | 13 (25.5) |
| Alcohol drinking, n (%) | 11 (26.2) | 10 (19.6) |
| FBG (mmol/L) | 5.5 ± 1.9 | 5.2 ± 1.3 |
| TG (mmol/L) | 3.2 ± 18.6 | 2.9 ± 7.2 |
| TC (mmol/L) | 5.2 ± 1.4 | 5.1 ± 1.1 |
| HDL (µmol/L) | 1.4 ± 0.3 | 1.3 ± 0.3 |
| LDL (µmol/L) | 3.3 ± 1.3 | 3.3 ± 1.0 |
| ALT (µmol/L) | 33.8 ± 20.0 | 29.9 ± 15.4 |
| BUN (mmol/L) | 5.7 ± 6.0 | 5.0 ± 5.2 |
| UCr (mmol/L) | 79.8 ± 15.5 | 73.1 ± 16.2 |
| UA (mmol/L) | 324.6 ± 86.3 | 309.7 ± 76.4 |
Quantitative data are shown as mean ± standard deviation, whereas numbers and percentage are provided for the qualitative data. BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; PP: Pulse pressure; MAP: Mean arterial pressure; HR: Heart rate; FBG: Fasting blood glucose; TG: Triglyceride; TC: Total cholesterol; HDL: High-density lipoprotein; LDL: Low density lipoprotein; ALT: Alanine aminotransferase; BUN: Blood urea nitrogen; UCr: Urine creatinine; UA: Uric acid; BMI = Weight/height2.